DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced today that its stockholders re-elected Kirby I. Bland, M.D., Gordon A. Troup and J. Frank Whitley, Jr. as Directors of the Company for terms ending at the 2012 Annual Meeting.
